Muramyl tripeptide phosphatidylethanolamine
Term · Oncology and biomedicine · MLC-T-ONC-005591
A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. Muramyl tripeptide phosphatidylethanolamine activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called L-MTP-PE, MEPACT, and mifamurtide.
| Identifier | MLC-T-ONC-005591 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | L-MTP-PE; MEPACT; mifamurtide |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005591",
"term": "Muramyl tripeptide phosphatidylethanolamine",
"field": "Oncology and biomedicine",
"definition": "A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. Muramyl tripeptide phosphatidylethanolamine activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called L-MTP-PE, MEPACT, and mifamurtide.",
"synonyms": [
"L-MTP-PE",
"MEPACT",
"mifamurtide"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/muramyl-tripeptide-phosphatidylethanolamine/"
}
Record 11,441 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.